Li Z, Jiang S, Wang J, Li W, Yang J, Liu W
Sci Adv. 2025; 11(3):eadr8841.
PMID: 39823328
PMC: 11740939.
DOI: 10.1126/sciadv.adr8841.
Petersen I, Morrison J, Petrovic A, Babic N, Metzendorf N, Godec A
Sci Rep. 2024; 14(1):30613.
PMID: 39715817
PMC: 11666562.
DOI: 10.1038/s41598-024-83627-6.
Cogill S, Lee J, Jeon M, Kim D, Chang Y
Cells. 2024; 13(10.
PMID: 38786013
PMC: 11119906.
DOI: 10.3390/cells13100789.
Marcellin D, Huang J
Viruses. 2024; 16(4).
PMID: 38675970
PMC: 11054372.
DOI: 10.3390/v16040629.
Choi E, Shusta E
Expert Opin Drug Deliv. 2023; 20(12):1789-1800.
PMID: 38007619
PMC: 10842915.
DOI: 10.1080/17425247.2023.2286371.
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.
Grimm H, Schumacher V, Schafer M, Imhof-Jung S, Freskgard P, Brady K
MAbs. 2023; 15(1):2261509.
PMID: 37823690
PMC: 10572082.
DOI: 10.1080/19420862.2023.2261509.
Application of In vitro transcytosis models to brain targeted biologics.
Deng K, Lu Y, Finnema S, Vangjeli K, Huang J, Huang L
PLoS One. 2023; 18(8):e0289970.
PMID: 37611031
PMC: 10446226.
DOI: 10.1371/journal.pone.0289970.
Affibody Molecules Intended for Receptor-Mediated Transcytosis via the Transferrin Receptor.
Hjelm L, Lindberg H, Stahl S, Lofblom J
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513868
PMC: 10383291.
DOI: 10.3390/ph16070956.
Endocrine Regulation of Microvascular Receptor-Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9-Mediated Regulation.
Mazura A, Pietrzik C
Pharmaceutics. 2023; 15(4).
PMID: 37111752
PMC: 10144601.
DOI: 10.3390/pharmaceutics15041268.
Standardized Preclinical Blood-Brain Barrier Mouse Assay Validates Endocytosis-Dependent Antibody Transcytosis Using Transferrin-Receptor-Mediated Pathways.
Morrison J, Petrovic A, Metzendorf N, Rofo F, Yilmaz C, Stenler S
Mol Pharm. 2023; 20(3):1564-1576.
PMID: 36808999
PMC: 9997753.
DOI: 10.1021/acs.molpharmaceut.2c00768.
Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells.
Liu G, Guzman E, Menon N, Langer R
Pharm Res. 2023; 40(1):3-25.
PMID: 36735106
PMC: 9897626.
DOI: 10.1007/s11095-023-03471-7.
Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism.
Liu N, Liang X, Yang C, Hu S, Luo Q, Luo H
Theranostics. 2022; 12(15):6646-6664.
PMID: 36185606
PMC: 9516238.
DOI: 10.7150/thno.76574.
Mucopolysaccharidoses and the blood-brain barrier.
Sahin O, Thompson H, Goodman G, Li J, Urayama A
Fluids Barriers CNS. 2022; 19(1):76.
PMID: 36117162
PMC: 9484072.
DOI: 10.1186/s12987-022-00373-5.
Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases.
Solomon M, Loeck M, Silva-Abreu M, Moscoso R, Bautista R, Vigo M
J Control Release. 2022; 349:1031-1044.
PMID: 35901858
PMC: 10550198.
DOI: 10.1016/j.jconrel.2022.07.022.
Modelling the Human Blood-Brain Barrier in Huntington Disease.
Vignone D, Paz O, Fini I, Cellucci A, Auciello G, Battista M
Int J Mol Sci. 2022; 23(14).
PMID: 35887162
PMC: 9321930.
DOI: 10.3390/ijms23147813.
Both the Complexity of Tight Junctions and Endothelial Transcytosis Are Increased During BBB Postnatal Development in Rats.
Li W, Zou J, Shang J, Gao C, Sun R, Liu R
Front Neurosci. 2022; 16:850857.
PMID: 35573303
PMC: 9095945.
DOI: 10.3389/fnins.2022.850857.
Syndapin-2 mediated transcytosis of amyloid-β across the blood-brain barrier.
M Leite D, Seifi M, Ruiz-Perez L, Nguemo F, Plomann M, Swinny J
Brain Commun. 2022; 4(1):fcac039.
PMID: 35233527
PMC: 8882007.
DOI: 10.1093/braincomms/fcac039.
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme.
Arguello A, Mahon C, Calvert M, Chan D, Dugas J, Pizzo M
J Exp Med. 2022; 219(3).
PMID: 35226042
PMC: 8932535.
DOI: 10.1084/jem.20211057.
The involvement of extracellular vesicles in the transcytosis of nanoliposomes through brain endothelial cells, and the impact of liposomal pH-sensitivity.
Reginald-Opara J, Svirskis D, Paek S, Tang M, OCarroll S, Dean J
Mater Today Bio. 2022; 13:100212.
PMID: 35198960
PMC: 8841812.
DOI: 10.1016/j.mtbio.2022.100212.
Polymeric Nanoparticles Properties and Brain Delivery.
Ribovski L, Hamelmann N, Paulusse J
Pharmaceutics. 2021; 13(12).
PMID: 34959326
PMC: 8705716.
DOI: 10.3390/pharmaceutics13122045.